Navigation Links
Former NASDAQ International President Among Execs Launching Firm to Access Global Markets
Date:11/10/2008

World Trade Center Dulles Airport Capital Partners will provide partnership for identifying expansion and investment opportunities.

Dubai, United Arab Emirates (PRWEB) November 10, 2008 -- World Trade Center Dulles Airport Capital Partners, an organization that assists select companies and investors seeking to access global markets, today announced its business launch at the World Trade Centers Association General Assembly in Dubai, United Arab Emirates.

WTC Capital Partners was formed by John T. Wall, former President, NASDAQ International and founder; Michael J. Runde, an executive with over 20 years of successful experience in the World Trade Centers organization and founder & President of World Trade Center Dulles Airport; and Harry M. Glazer, an expert in venture capital and private equity who co-founded MindShare and is Special Counsel to Kelley Drye. The new firm is augmented by best-of-breed executives with relevant domain expertise from around the world.    

In making the announcement, WTC Capital Partners co-chairman John T. Wall stated that "Geographic diversity has become a critical asset as economies and currencies fluctuate. In my three decades at NASDAQ, it was evident that in order for a company to provide its stakeholders with maximum value, it must participate in global markets." "We are pleased to offer unique value in coupling our experience in global expansion and capital markets with the established relationships among World Trade Centers and science and technology parks in over 100 countries."

Michael J. Runde, CEO of WTC Capital Partners related that 'the WTC Dulles Airport is the first World Trade Center to be admitted to the International Association of Science Parks. "WTC Capital Partners was created to accelerate the move from innovation to commercialization for companies internationally. We can actually lower risk and improve results for our portfolio companies through experience and trusted relationships."

'Having spent my entire career mentoring emerging growth companies throughout their lifecycle, I am excited to team with such respected partners in guiding emerging growth companies to a global presence,' said Harry M. Glazer, co-chairman of WTC Capital Partners.

The new organization operates from just outside Washington, DC, in one of the most sustainable economies in the United States, due to its technology base and global focus.

About World Trade Center Dulles Airport Capital Partners:
WTC Capital Partners is a respected organization, based just outside of Washington, DC, that partners with a few select companies and investors seeking expansion opportunities globally. Focused primarily on emerging growth firms, the company offers a partnership approach in identifying, assessing and executing on global capital market opportunities. This is accomplished by coupling deep experience with trusted relationships and access to World Trade Centers and science parks in over 100 countries.

WTC Capital Partners was created to respond to a recognized need identified by both the World Trade Centers Association and International Association of Science Parks. This need led to a first-of-its-kind cooperative agreement between these two global organizations.

The unique benefit of WTC Capital Partners is a capability for companies to speed products and services to market and lower risk in doing so, as well as the opportunity to be identified by investors for funding and acquisition. Further information about the company can be found by visiting www.wtcdullescp.com.

Media contact:
Washington, DC
John T. Wall, Co-Chairman
WTC Dulles Airport Capital Partners
wall @ wtcdullescp.com

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1591264.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
2. Former Telomolecular CEO Clarifies SEC Settlement
3. Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado
4. Former Cables to Go/Lastar Inc. Employee's Move to Form American Consumer Cables Pays Off
5. Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
6. Former Speaker of the House Newt Gingrich Featured Wednesday
7. Cliff Consulting, Inc. Adds Two Influential Former Executives to Its Team - Banker Mary P. Carryer and Healthcare IT Leader Robert Goldstein
8. Insmed Partners With Bill Thomas, Former House Ways and Means Chairman, as Strategic Advisor
9. ADVENTRX Settles Dispute With Former Licensee
10. Palladian Muscular Skeletal Health (formerly Prism Health Networks) to Promote Collaborative, Expanded Practice Model at Major Insurance Conference in June
11. Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Former NASDAQ International President Among Execs Launching Firm to Access Global Markets 
(Date:6/23/2016)... 2016  The Prostate Cancer Foundation (PCF) is pleased to announce ... cures for prostate cancer. Members of the Class of 2016 were selected from ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , a ... $1 million in debt financing from Silicon Valley Bank ... automation and to advance its drug development efforts, as ... facility. "SVB has been an incredible strategic ... services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... , ... STACS DNA Inc., the sample tracking software company, today announced that ... joined STACS DNA as a Field Application Specialist. , “I am thrilled that ... of STACS DNA. “In further expanding our capacity as a scientific integrator, Hays brings ...
(Date:6/23/2016)... June 23, 2016 Apellis Pharmaceuticals, Inc. ... clinical trials of its complement C3 inhibitor, APL-2. ... multiple ascending dose studies designed to assess the ... subcutaneous injection in healthy adult volunteers. ... as a single dose (ranging from 45 to ...
Breaking Biology Technology:
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC ... today announced the opening of an IoT Center of ... strengthen and expand the development of embedded iris biometric ... unprecedented level of convenience and security with unmatched biometric ... one,s identity aside from DNA. EyeLock,s platform uses video ...
(Date:5/3/2016)... Lithuania , May 3, 2016  Neurotechnology, ... released the MegaMatcher Automated Biometric Identification System ... of large-scale multi-biometric projects. MegaMatcher ABIS can process ... accuracy using any combination of fingerprint, face or ... MegaMatcher SDK and MegaMatcher Accelerator ...
(Date:4/26/2016)... India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a product ... and Onegini today announced a partnership to integrate ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... to provide their customers enhanced security to access ...
Breaking Biology News(10 mins):